![]() |
Volumn 17, Issue 5, 2010, Pages 423-425
|
Loss of 53BP1 Is a Gain for BRCA1 Mutant Cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRCA1 PROTEIN;
CISPLATIN;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;
NUCLEAR PROTEIN;
PLATINUM DERIVATIVE;
PROTEIN 53BP1;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
BREAST CANCER;
CANCER GENETICS;
CANCER RESISTANCE;
CANCER SUSCEPTIBILITY;
CARCINOGENESIS;
CHROMOSOMAL INSTABILITY;
DNA REPAIR;
DOUBLE STRANDED DNA BREAK;
DRUG TARGETING;
GENE DELETION;
GENE MUTATION;
HOMOLOGOUS RECOMBINATION;
HUMAN;
MUTATIONAL ANALYSIS;
NONHUMAN;
OVARY CANCER;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN DEPLETION;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
|
EID: 77952109779
PISSN: 15356108
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ccr.2010.04.021 Document Type: Short Survey |
Times cited : (20)
|
References (10)
|